20162019

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Federico Pozzo is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 2 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

KRAS, NRAS, and BRAF mutations are highly enriched in trisomy 12 chronic lymphocytic leukemia and are associated with shorter treatment-free survival

Vendramini, E., Bomben, R., Pozzo, F., Benedetti, D., Bittolo, T., Rossi, F. M., Dal Bo, M., Rabe, K. G., Pozzato, G., Zaja, F., Chiarenza, A., Di Raimondo, F., Braggio, E., Parikh, S. A., Kay, N. E., Shanafelt, T. D., Del Poeta, G., Gattei, V. & Zucchetto, A., Aug 1 2019, In : Leukemia. 33, 8, p. 2111-2115 5 p.

Research output: Contribution to journalLetter

Open Access

NOTCH1 mutations are associated with high CD49d expression in chronic lymphocytic leukemia: Link between the NOTCH1 and the NF-κ B pathways

Benedetti, D., Tissino, E., Pozzo, F., Bittolo, T., Caldana, C., Perini, C., Martorelli, D., Bravin, V., D'Agaro, T., Rossi, F. M., Bomben, R., Santinelli, E., Zaja, F., Pozzato, G., Chiarenza, A., Di Raimondo, F., Del Poeta, G., Rossi, D., Gaidano, G., Dal Bo, M. & 2 others, Gattei, V. & Zucchetto, A., Mar 1 2018, In : Leukemia. 32, 3, p. 654-662 9 p.

Research output: Contribution to journalArticle

  • Mutational status of IGHV is the most reliable prognostic marker in trisomy 12 chronic lymphocytic leukemia

    Bulian, P., Bomben, R., Dal Bo, M., Zucchetto, A., Rossi, F. M., Degan, M., Pozzo, F., Bittolo, T., Bravin, V., D’Agaro, T., Cerri, M., Chiarenza, A., Chaffee, K. G., Condoluci, A., D’Arena, G., Spina, M., Zaja, F., Pozzato, G., Di Raimondo, F., Rossi, D. & 4 others, Del Poeta, G., Gaidano, G., Shanafelt, T. D. & Gattei, V., Oct 27 2017, In : Haematologica. 102, 11, p. e443-e446

    Research output: Contribution to journalLetter

    Mutational status of IGHV is the most reliable prognostic marker in trisomy 12 chronic lymphocytic leukemia

    Bulian, P., Bomben, R., Bo, M. D., Zucchetto, A., Rossi, F. M., Degan, M., Pozzo, F., Bittolo, T., Bravin, V., D'Agaro, T., Cerri, M., Chiarenza, A., Chaffee, K. G., Condoluci, A., D'Arena, G., Spina, M., Zaja, F., Pozzato, G., Di Raimondo, F., Rossi, D. & 4 others, Poeta, G. D., Gaidano, G., Shanafelt, T. D. & Gattei, V., Nov 2017, In : Haematologica. 102, 11, p. e443-e446

    Research output: Contribution to journalArticle

    Mutational status of IGHV is the most reliable prognostic marker in trisomy 12 chronic lymphocytic leukemia

    Bulian, P., Bomben, R., Dal Bo, M., Zucchetto, A., Rossi, F. M., Degan, M., Pozzo, F., Bittolo, T., Bravin, V., D’Agaro, T., Cerri, M., Chiarenza, A., Chaffee, K. G., Condoluci, A., D’Arena, G., Spina, M., Zaja, F., Pozzato, G., Di Raimondo, F., Rossi, D. & 4 others, Del Poeta, G., Gaidano, G., Shanafelt, T. D. & Gattei, V., Oct 27 2017, In : Haematologica. 102, 11, p. e443-e446 3 p.

    Research output: Contribution to journalLetter